PLIANT THERAPEUTICS, INC. Debt Securities Available For Sale Excluding Accrued Interest
PLIANT THERAPEUTICS, INC. (PLRX) had Debt Securities Available For Sale Excluding Accrued Interest of $150.36 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets
us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest · last filed 2026-08-11
- 2026-06-30: Debt Securities Available For Sale Excluding Accrued Interest $150.36M.
- 2026-03-31: Debt Securities Available For Sale Excluding Accrued Interest $162.45M.
- 2025-12-31: Debt Securities Available For Sale Excluding Accrued Interest $173.80M.
- 2025-09-30: Debt Securities Available For Sale Excluding Accrued Interest $226.91M.
| Period end | Debt Securities Available For Sale Excluding Accrued Interest |
|---|---|
| 2026-06-30 | $150.36M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $162.45M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $173.80M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $226.91M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $248.67M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $278.26M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $339.36M 10-K · filed 2026-03-11 |
| 2024-09-30 | $383.53M 10-Q · filed 2024-11-07 |
| 2023-12-31 | $488.25M 10-K · filed 2025-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |